A detailed history of Amundi transactions in Simulations Plus, Inc. stock. As of the latest transaction made, Amundi holds 932 shares of SLP stock, worth $26,636. This represents 0.0% of its overall portfolio holdings.

Number of Shares
932
Previous 932 -0.0%
Holding current value
$26,636
Previous $45,000 35.56%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$38.46 - $50.95 $35,844 - $47,485
932 New
932 $45,000
Q3 2023

Nov 14, 2023

BUY
$40.03 - $51.51 $179,214 - $230,610
4,477 Added 54.65%
12,669 $528,000
Q2 2023

Aug 14, 2023

BUY
$40.45 - $48.0 $221,625 - $262,992
5,479 Added 201.95%
8,192 $354,000
Q3 2022

Nov 14, 2022

BUY
$47.75 - $66.88 $129,545 - $181,445
2,713 New
2,713 $139,000
Q3 2021

Nov 15, 2021

SELL
$38.45 - $55.66 $108,659 - $157,295
-2,826 Closed
0 $0
Q2 2021

Aug 16, 2021

BUY
$49.67 - $68.96 $140,367 - $194,880
2,826 New
2,826 $155,000

Others Institutions Holding SLP

About Simulations Plus, Inc.


  • Ticker SLP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 20,297,700
  • Market Cap $580M
  • Description
  • Simulations Plus, Inc. develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. It operates through four segments: Simulations Plus, Cognigen, DILIsym, and Lixoft. The company offers GastroPlus, which sim...
More about SLP
Track This Portfolio

Track Amundi Portfolio

Follow Amundi and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Amundi, based on Form 13F filings with the SEC.

News

Stay updated on Amundi with notifications on news.